Delivery Order SPE2DB25D9348-SPE2DB25FNMVW
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 for Jakafi 10 mg tablets (60-count units) by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the vendor's Park Ridge, Illinois facility. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, valued at $48.4K by the Defense Logistics Agency for 60 tablets of Jakafi 20 mg. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a single supply fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to support federal medical supply needs. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, valued at $36,115.27, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 21, 2025, for the supply of Jakafi 10 mg tablets (60-count packages). The contract utilizes a firm fixed-price structure with no set-aside designation and carries an ultimate completion date of July 22, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,999.80 by the Defense Logistics Agency on September 11, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a continuation of the company's substantial pharmaceutical supply relationship with the Department of Defense. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $72,880.74 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The award was issued under a firm fixed-price contract with no set-aside designation and is set for ultimate completion by August 12, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency (DLA) for JAKAFI 20 mg tablets (60-count units) with a ceiling value of $12,089.78. This firm fixed-price delivery order, which has an ultimate completion date of August 4, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMVWDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,089.78, represents a single line-item procurement without a set-aside designation, with an ultimate completion date of August 22, 2025. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle through November 2026 that authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Jakafi (ruxolitinib) is a prescription medication used primarily in the treatment of myelofibrosis and polycythemia vera, conditions commonly managed within Department of Defense healthcare systems. This delivery order aligns with DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, leveraging its robust portfolio of branded and generic prescription drug distributions to military medical facilities. The company's consistent performance as a woman-owned small business has positioned it as a preferred vendor for DLA pharmaceutical procurements, enabling efficient fulfillment of medical supply requirements across DoD healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/21/25 |